agilon health (NYSE:AGL) Trading Up 4.8%

agilon health, inc. (NYSE:AGL)’s stock price rose 4.8% on Wednesday . The company traded as high as $6.59 and last traded at $6.58. Approximately 2,561,730 shares traded hands during mid-day trading, a decline of 49% from the average daily volume of 5,057,788 shares. The stock had previously closed at $6.28.

Wall Street Analysts Forecast Growth

AGL has been the subject of a number of analyst reports. Truist Financial boosted their price objective on shares of agilon health from $6.40 to $6.50 and gave the company a “hold” rating in a research report on Friday, May 24th. Barclays began coverage on shares of agilon health in a research report on Wednesday, March 6th. They set an “underweight” rating and a $5.00 price target for the company. Baird R W raised shares of agilon health to a “hold” rating in a research report on Thursday, May 30th. Citigroup began coverage on shares of agilon health in a research report on Monday, April 22nd. They set a “neutral” rating and a $6.00 price target for the company. Finally, Robert W. Baird began coverage on shares of agilon health in a research report on Thursday, May 30th. They set a “neutral” rating and a $6.00 price target for the company. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $9.03.

agilon health Stock Up 4.3 %

The firm’s 50 day moving average price is $5.83 and its two-hundred day moving average price is $6.90. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last announced its earnings results on Tuesday, May 7th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.03. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.62 billion. agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. On average, research analysts predict that agilon health, inc. will post -0.34 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in AGL. Capital International Investors raised its holdings in agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after acquiring an additional 9,263,296 shares in the last quarter. Capital World Investors raised its holdings in agilon health by 7.4% in the fourth quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock valued at $692,992,000 after acquiring an additional 3,813,214 shares in the last quarter. Morgan Stanley raised its holdings in agilon health by 8.9% in the third quarter. Morgan Stanley now owns 44,819,378 shares of the company’s stock valued at $795,992,000 after acquiring an additional 3,674,311 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in agilon health by 46.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock valued at $127,256,000 after acquiring an additional 3,195,087 shares in the last quarter. Finally, Wellington Management Group LLP raised its holdings in agilon health by 8.3% in the third quarter. Wellington Management Group LLP now owns 41,318,777 shares of the company’s stock valued at $733,821,000 after acquiring an additional 3,162,094 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.